# CVE-2025-61940

## Summary

- **CVE ID:** CVE-2025-61940
- **Severity:** HIGH
- **CVSS Score:** 8.7 (CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N)
- **CWE:** CWE-603
- **Published:** Dec 2, 2025
- **Last Modified:** Mar 12, 2026

## Description

NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.

## Affected Products

- Mirion Medical — EC2 Software NMIS BioDose (0)
- Mirion Medical — EC2 Software NMIS BioDose (23.0)

## References

- [CNA](https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01)

## Exploitation Prediction (EPSS)

- **EPSS Score:** 0.32%
- **EPSS Percentile:** 25.1

---
_Exported from OnDuty AI Vulnerability Intelligence on 2026-09-10._